Switch to:
Novo Nordisk A/S (NYSE:NVO)
Cash Flow from Operations
$4,631 Mil (TTM As of Dec. 2013)

Cash flow from operations refers to the cash brought in through a company’'s normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the three months ended in Dec. 2013, Novo Nordisk A/S's Net Income From Continuing Operations was $1,105 Mil. Its DDA was $511 Mil. Its Change In Working Capital was $53 Mil. Its cash flow from deferred tax was $0 Mil. Its Cash Flow from Discontinued Operations was $0 Mil. And its Cash Flow from Others was $-688 Mil. In all, Novo Nordisk A/S's Cash Flow from Operations for the three months ended in Dec. 2013 was $980 Mil.


Definition

Cash flow from operations refers to the cash brought in through a company’'s normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Novo Nordisk A/S's Cash Flow from Operations for the fiscal year that ended in Dec. 2013 is calculated as:

Cash Flow from Operations(A: Dec. 2013 )
=Net Income From Continuing Operations+DDA+Change In Working Capital+Deferred Tax
=4596.45920788+510.859645921+-48.3664902354+0
+Cash Flow from Discontinued Operations+Cash Flow from Others
+0+-324.146742106
=4,735

Novo Nordisk A/S's Cash Flow from Operations for the quarter that ended in Dec. 2013 is

Cash Flow from Operations(Q: Dec. 2013 )
=Net Income From Continuing Operations+DDA+Change In Working Capital+Deferred Tax
=1104.763643+510.859645921+52.7468516153+0
+Cash Flow from Discontinued Operations+Cash Flow from Others
+0+-687.899251688
=980

Novo Nordisk A/S Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2013 was 1235.15024458 (Mar. 2013 ) + 1278.16777817 (Jun. 2013 ) + 1137.39480424 (Sep. 2013 ) + 980.470888848 (Dec. 2013 ) = $4,631 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

Cash flow from operations contains six items:

1. Net Income From Continuing Operations:
Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Novo Nordisk A/S's net income from continuing operations for the three months ended in Dec. 2013 was $1,105 Mil.

2. Depreciation, Depletion and Amortization:
Depreciation is a present expense that accounts for the past cost of an asset that is now providing benefits.
Depletion and amortization are synonyms for depreciation.
Generally:
• The term “depreciation” is used when discussing man made tangible assets
• The term “depletion” is used when discussing natural tangible assets
• The term “amortization” is used when discussing intangible assets

Novo Nordisk A/S's depreciation, depletion and amortization for the three months ended in Dec. 2013 was $511 Mil.

3. Change In Working Capital:
Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities. Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow.

Novo Nordisk A/S's change in working capital for the three months ended in Dec. 2013 was $53 Mil. It means Novo Nordisk A/S's working capital increased by $53 Mil from Sep. 2013 to Dec. 2013 .

4. Deferred Tax:
It is the cash flow generated from deferred tax.

Novo Nordisk A/S's cash flow from deferred tax for the three months ended in Dec. 2013 was $0 Mil.

5. Cash Flow from Discontinued Operations:
Cash received by a company that comes from the sale of part of business.

Novo Nordisk A/S's cash flow from discontinued operations for the three months ended in Dec. 2013 was $0 Mil.

6. Cash Flow from Others:
These are cash differences caused by the change of inventory, accounts payable, accounts receivable etc. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its account receivables will rise, and its cash position will grow more slowly (or even shrink).

Novo Nordisk A/S's cash flow from others for the three months ended in Dec. 2013 was $-688 Mil.


Related Terms

Net Income From Continuing Operations, Depreciation, Depletion and Amortization, Change In Working Capital, Cash Flow from Discontinued Operations, Cash Flow from Others, Cash Flow from Investing


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Novo Nordisk A/S Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
NetIncomeFromContinuingOperations 8909521,1251,6871,7172,0642,5832,9683,8214,596
CF_DDA 336314373596435489443475480511
ChangeInWorkingCapital 19-64-179-203-100-53537549-48
CF_DeferredTax 0000000000
Cash Flow from Disc. Op. 0000000000
Cash Flow from Others 10321231-103239448451192-390-324
Cash Flow from Operations 1,3481,4141,3501,9772,2922,9473,5303,7113,9604,735

Novo Nordisk A/S Quarterly Data

Sep11Dec11Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13
NetIncomeFromContinuingOperations 7752,9688258829861,0261,0451,1821,1741,105
CF_DDA 0475000480000511
ChangeInWorkingCapital 122109-33729185168-319-4828253
CF_DeferredTax 0000000000
Cash Flow from Disc. Op. 0000000000
Cash Flow from Others 533-2,861500269214-1,404509144-318-688
Cash Flow from Operations 1,4306919881,1801,3852701,2351,2781,137980
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide